CN1944661A - 胞磷胆碱钠的制备方法 - Google Patents
胞磷胆碱钠的制备方法 Download PDFInfo
- Publication number
- CN1944661A CN1944661A CN 200610096512 CN200610096512A CN1944661A CN 1944661 A CN1944661 A CN 1944661A CN 200610096512 CN200610096512 CN 200610096512 CN 200610096512 A CN200610096512 A CN 200610096512A CN 1944661 A CN1944661 A CN 1944661A
- Authority
- CN
- China
- Prior art keywords
- citicoline sodium
- preparation
- consumption
- liquid
- yeast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YWAFNFGRBBBSPD-OCMLZEEQSA-M sodium;[[(2r,3s,4r,5r)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound [Na+].O[C@@H]1[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 YWAFNFGRBBBSPD-OCMLZEEQSA-M 0.000 title claims abstract description 45
- 229960004774 citicoline sodium Drugs 0.000 title claims abstract description 44
- 238000004519 manufacturing process Methods 0.000 title description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 36
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims abstract description 33
- 238000000926 separation method Methods 0.000 claims abstract description 26
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 25
- 238000002360 preparation method Methods 0.000 claims abstract description 23
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 15
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 claims abstract description 12
- 229950004354 phosphorylcholine Drugs 0.000 claims abstract description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 11
- 239000008103 glucose Substances 0.000 claims abstract description 11
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 9
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 5
- 239000000047 product Substances 0.000 claims description 38
- 239000007787 solid Substances 0.000 claims description 30
- 238000006243 chemical reaction Methods 0.000 claims description 27
- 239000000243 solution Substances 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 claims description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 239000012043 crude product Substances 0.000 claims description 12
- 238000002425 crystallisation Methods 0.000 claims description 12
- 230000008025 crystallization Effects 0.000 claims description 12
- 239000003513 alkali Substances 0.000 claims description 11
- 230000001476 alcoholic effect Effects 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 238000001179 sorption measurement Methods 0.000 claims description 7
- 101800000263 Acidic protein Proteins 0.000 claims description 6
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims description 6
- 238000003916 acid precipitation Methods 0.000 claims description 6
- 230000009849 deactivation Effects 0.000 claims description 6
- 238000010612 desalination reaction Methods 0.000 claims description 6
- 238000001471 micro-filtration Methods 0.000 claims description 6
- 102000039446 nucleic acids Human genes 0.000 claims description 6
- 108020004707 nucleic acids Proteins 0.000 claims description 6
- 150000007523 nucleic acids Chemical class 0.000 claims description 6
- 239000013049 sediment Substances 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 238000010792 warming Methods 0.000 claims description 6
- 230000003570 biosynthesizing effect Effects 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 229930183912 Cytidylic acid Natural products 0.000 claims description 3
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 239000003054 catalyst Substances 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 230000008014 freezing Effects 0.000 claims 1
- 238000007710 freezing Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 7
- 102000004190 Enzymes Human genes 0.000 abstract description 6
- 108090000790 Enzymes Proteins 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract description 2
- 230000036983 biotransformation Effects 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 239000003456 ion exchange resin Substances 0.000 abstract description 2
- 229920003303 ion-exchange polymer Polymers 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 239000011942 biocatalyst Substances 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical class OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 230000006920 protein precipitation Effects 0.000 description 3
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- ZWIADYZPOWUWEW-XVFCMESISA-N CDP Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O1 ZWIADYZPOWUWEW-XVFCMESISA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 229960001284 citicoline Drugs 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- PCDQPRRSZKQHHS-CCXZUQQUSA-N Cytarabine Triphosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 PCDQPRRSZKQHHS-CCXZUQQUSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- -1 choline Cytidine diphosphate ester Chemical class 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100965128A CN100564537C (zh) | 2006-09-28 | 2006-09-28 | 胞磷胆碱钠的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100965128A CN100564537C (zh) | 2006-09-28 | 2006-09-28 | 胞磷胆碱钠的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1944661A true CN1944661A (zh) | 2007-04-11 |
CN100564537C CN100564537C (zh) | 2009-12-02 |
Family
ID=38044311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100965128A Active CN100564537C (zh) | 2006-09-28 | 2006-09-28 | 胞磷胆碱钠的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100564537C (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102010454A (zh) * | 2010-12-02 | 2011-04-13 | 胡建荣 | 一种胞磷胆碱钠化合物及其新方法 |
CN103509073A (zh) * | 2013-08-29 | 2014-01-15 | 洪军 | 一种胞磷胆碱钠化合物 |
CN103509074A (zh) * | 2013-10-10 | 2014-01-15 | 江西科技师范大学 | 核苷二磷酸6-脱氧-l-吡喃糖的合成方法 |
CN103849666A (zh) * | 2013-05-08 | 2014-06-11 | 开平牵牛生化制药有限公司 | 一种固定化酶催化生产胞磷胆碱钠的方法 |
CN104031105A (zh) * | 2014-06-06 | 2014-09-10 | 浙江天冉药物研究有限公司 | 一种胞磷胆碱钠的制备方法 |
CN104592335A (zh) * | 2014-12-24 | 2015-05-06 | 江西科技师范大学 | 一种合成核苷二磷酸胆碱钠盐的方法 |
CN105732752A (zh) * | 2016-03-18 | 2016-07-06 | 新乡学院 | 一种胞二磷胆碱及其合成方法 |
CN106146590A (zh) * | 2016-06-29 | 2016-11-23 | 陈建峰 | 一种胞磷胆碱钠的制备方法 |
CN109836468A (zh) * | 2017-11-24 | 2019-06-04 | 苏州华赛生物工程技术有限公司 | 一种从微生物发酵液中分离纯化胞二磷胆碱钠的方法 |
CN113769794A (zh) * | 2021-07-06 | 2021-12-10 | 沁浩膜技术(厦门)有限公司 | 一种连续脱除胞磷胆碱钠中杂质的离子交换***及方法 |
-
2006
- 2006-09-28 CN CNB2006100965128A patent/CN100564537C/zh active Active
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102010454B (zh) * | 2010-12-02 | 2012-03-07 | 胡建荣 | 一种胞磷胆碱钠化合物及其新方法 |
CN102010454A (zh) * | 2010-12-02 | 2011-04-13 | 胡建荣 | 一种胞磷胆碱钠化合物及其新方法 |
CN103849666B (zh) * | 2013-05-08 | 2015-09-02 | 开平牵牛生化制药有限公司 | 一种固定化酶催化生产胞磷胆碱钠的方法 |
CN103849666A (zh) * | 2013-05-08 | 2014-06-11 | 开平牵牛生化制药有限公司 | 一种固定化酶催化生产胞磷胆碱钠的方法 |
CN103509073A (zh) * | 2013-08-29 | 2014-01-15 | 洪军 | 一种胞磷胆碱钠化合物 |
CN103509073B (zh) * | 2013-08-29 | 2016-01-06 | 洪军 | 一种胞磷胆碱钠化合物 |
CN103509074A (zh) * | 2013-10-10 | 2014-01-15 | 江西科技师范大学 | 核苷二磷酸6-脱氧-l-吡喃糖的合成方法 |
CN104031105B (zh) * | 2014-06-06 | 2015-07-15 | 回音必集团(江西)东亚制药有限公司 | 一种胞磷胆碱钠的制备方法 |
CN104031105A (zh) * | 2014-06-06 | 2014-09-10 | 浙江天冉药物研究有限公司 | 一种胞磷胆碱钠的制备方法 |
CN104592335A (zh) * | 2014-12-24 | 2015-05-06 | 江西科技师范大学 | 一种合成核苷二磷酸胆碱钠盐的方法 |
CN105732752A (zh) * | 2016-03-18 | 2016-07-06 | 新乡学院 | 一种胞二磷胆碱及其合成方法 |
CN106146590A (zh) * | 2016-06-29 | 2016-11-23 | 陈建峰 | 一种胞磷胆碱钠的制备方法 |
CN109836468A (zh) * | 2017-11-24 | 2019-06-04 | 苏州华赛生物工程技术有限公司 | 一种从微生物发酵液中分离纯化胞二磷胆碱钠的方法 |
CN113769794A (zh) * | 2021-07-06 | 2021-12-10 | 沁浩膜技术(厦门)有限公司 | 一种连续脱除胞磷胆碱钠中杂质的离子交换***及方法 |
CN113769794B (zh) * | 2021-07-06 | 2024-04-05 | 沁浩膜技术(厦门)有限公司 | 一种连续脱除胞磷胆碱钠中杂质的离子交换***及方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100564537C (zh) | 2009-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1944661A (zh) | 胞磷胆碱钠的制备方法 | |
CN104774881B (zh) | 一种生物催化生产L-α-氨基丁酸的方法 | |
CN1896259A (zh) | 一种生产γ-氨基丁酸的方法及其专用反应柱 | |
CN104762347A (zh) | 一种三磷酸腺苷(atp)的生产方法 | |
CN108611380A (zh) | 一种选择性合成2,5-二羟甲基呋喃的方法 | |
CN102268057B (zh) | 一种3’,5’-环腺苷单磷酸的结晶方法 | |
CN1298860C (zh) | γ-氨基丁酸的酶法转化制备方法 | |
CN1775791A (zh) | 一种制备2-脱氧-d-葡萄糖的新方法 | |
CN101503432B (zh) | 5'-脱氧核苷单磷酸的制备方法 | |
CN115772549A (zh) | 一种从发酵液中提取含痕量烟酸的烟酰胺制备方法 | |
CN109369731A (zh) | 一种脱除木糖生产过程中葡萄糖的方法 | |
CN112940058B (zh) | 一种氟标签及其制备方法、辅助的酶法合成寡糖链的方法 | |
CN100392090C (zh) | 酶法拆分制备l-蛋氨酸-15n和d-蛋氨酸-15n的方法 | |
CN101285085A (zh) | 一种利用整细胞催化合成腺苷甲硫氨酸的方法 | |
CN110372606B (zh) | 一种从微生物发酵液中分离纯化胞嘧啶的方法 | |
CN103172542A (zh) | 一种分离纯化l-瓜氨酸的方法 | |
CN109321613B (zh) | 一种生产d-甘露糖的方法 | |
CN1266161C (zh) | 单磷酸阿糖腺苷的合成工艺 | |
CN101671716A (zh) | 生物酶不对称转化生产d-苯丙氨酸的方法 | |
CN102226208B (zh) | D-天冬酰胺的制备方法 | |
CN104313071A (zh) | 高纯L-α-氨基酸的生物合成方法 | |
CN106381316B (zh) | 一种α-酮戊二酸钠的制备方法及提纯方法 | |
CN1616475A (zh) | 胞苷-5′-一磷酸的制备方法 | |
CN116970666B (zh) | 一种生物酶法制备的三磷酸腺苷二钠及其应用 | |
CN104928342A (zh) | 一种制备s-腺苷蛋氨酸和d-蛋氨酸的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SUZHOU TIANMA SPECIALTY CHEMICAL CO., LTD. Free format text: FORMER OWNER: TIANJI BIOLOGICAL PHARMACEUTICAL CO., LTD., SUZHOU TIANMA MEDICINE GROUP Effective date: 20140604 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140604 Address after: Town of Wuzhong District road Suzhou city Jiangsu province 215101 No. 199-1 Patentee after: Suzhou Tianma Fine Chemical Product Co., Ltd. Address before: Mudu Garden Road Suzhou city Jiangsu province 215101 No. 199 Patentee before: Suzhou Tianma Group Tianji Bio-Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180807 Address after: No. 122, Hu Guan Zhen Lu Qing Road, Suzhou, Jiangsu, Jiangsu Patentee after: Suzhou Tianma Pharmaceutical Co., Ltd. Address before: 215101 Huayuan East Road, Mu Du Town, Wuzhong District, Suzhou, Jiangsu 199-1 Patentee before: Suzhou Tianma Fine Chemical Product Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Suzhou City, Jiangsu province 215000 Guan Hu Zhen Hu Qing Road No. 122 Patentee after: Suzhou Zhengji Pharmaceutical Co.,Ltd. Address before: Suzhou City, Jiangsu province 215000 Guan Hu Zhen Hu Qing Road No. 122 Patentee before: SUZHOU TIANMA PHARMACEUTICAL Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |